StockData

NuCana plc (NCNA) stock

NCNANasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 20-F on Mar 19, 2026Score 1/30
$0.83−0.06 (-6.43%)

Close on Nov 18, 2026Market cap $3.47MP/E –Yield –

NuCana shares outstanding

Diluted shares outstanding: the weighted share count used for earnings per share, adjusted for stock splits.

NuCana's shares outstanding was 20.93B at Jun 30, 2026. For fiscal 2025 it was 11.23B, up 15038.7% from the year before. Over ten years it grew 84.9% a year on average. The highest annual figure on record is 11.23B in fiscal 2025.

Annual shares outstanding

PeriodPeriod endValueChange
FY2025Dec 31, 202511.23B+15038.7%
FY2024Dec 31, 202474M+41.1%
FY2023Dec 31, 202353M+0.6%
FY2022Dec 31, 202252M+0.4%
FY2021Dec 31, 202152M+37.4%
FY2020Dec 31, 202038M+17.2%
FY2019Dec 31, 201932M+1.1%
FY2018Dec 31, 201832M+22.6%
FY2017Dec 31, 201726M+8.1%
FY2016Dec 31, 201624M+0.0%
FY2015Dec 31, 201524M–

Quarterly shares outstanding

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 202620.93B+39995.3%
Q2 FY2025Jun 30, 20255.17B+9814.1%
Q2 FY2024Jun 30, 202457M+8.6%
Q2 FY2023Jun 30, 202352M+0.4%
Q2 FY2022Jun 30, 202252M+1.1%
Q4 FY2021Dec 31, 202152M+1.8%
Q3 FY2021Sep 30, 202152M+48.6%
Q2 FY2021Jun 30, 202152M+59.7%
Q1 FY2021Mar 31, 202152M+59.0%
Q4 FY2020Dec 31, 202051M+57.9%
Q3 FY2020Sep 30, 202035M+8.4%
Q2 FY2020Jun 30, 202033M+1.3%
Q1 FY2020Mar 31, 202032M+0.8%
Q4 FY2019Dec 31, 201932M+0.8%
Q3 FY2019Sep 30, 201932M+1.0%
Q2 FY2019Jun 30, 201932M+1.3%
Q1 FY2019Mar 31, 201932M+1.3%
Q4 FY2018Dec 31, 201832M+132988.1%
Q3 FY2018Sep 30, 201832M+132445.0%
Q2 FY2018Jun 30, 201832M–
Q1 FY2018Mar 31, 201832M–
Q3 FY2017Sep 30, 20170M–
Q2 FY2017Jun 30, 20170M–

More NuCana figures

See a number that looks wrong?